02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(2002): Bohm M+, <strong>Drug</strong> Saf 25(8), 599 (with<br />

hydrochlorothiazide)<br />

(2001): Levine B, Curr Med Res Opin 17(1), 8<br />

EPTIFIBATIDE<br />

Trade name: Integrilin (Millennium) (Schering)<br />

Indications: Acute coronary syndrome, unstable angina<br />

Category: Antiplatelet; Glycoprotein IIb / IIIa inhibitor<br />

Half-life: 2.5 hours<br />

Clinically important, potentially hazardous interactions<br />

with: fondaparinux<br />

Reactions<br />

Other<br />

Anaphylactoid reactions/Anaphylaxis (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!